Evidence map›Paper›PMID 41463219›Full record

ArticleCancers2025

Development and Internal Evaluation of AI-Assisted Cervical Muscle-Based Scores (FUNC-RISK) in Head and Neck Cancer: A Pilot Study.

Laura Ferrera-Alayón, Fiorella Ximena Palmas-Candia, Barbara Salas-Salas, Jesús María González-Martín, Raquel Diaz-Saavedra, Anais Ramos-Ortiz, Pedro C Lara, Marta Lloret Sáez-Bravo

Abstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Laura Ferrera-AlayónDepartment of Clinical Sciences, University of Las Palmas de Gran Canaria (ULPGC), 35010 Las Palmas de Gran Canaria, Spain.
Fiorella Ximena Palmas-CandiaEndocrinology and Nutrition Department, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.ORCID 0000-0002-9941-1816
Barbara Salas-SalasDepartment of Radiation Oncology, University Hospital Dr Negrín, 35010 Las Palmas de Gran Canaria, Spain.ORCID 0000-0002-4336-4045
Jesús María González-MartínDepartment of Medicine, Fernando Pessoa Canarias University, 35001 Las Palmas de Gran Canaria, Spain.
Raquel Diaz-SaavedraDepartment of Radiation Oncology, University Hospital Dr Negrín, 35010 Las Palmas de Gran Canaria, Spain.
Anais Ramos-OrtizDepartment of Radiation Oncology, University Hospital Dr Negrín, 35010 Las Palmas de Gran Canaria, Spain.
Pedro C LaraDepartment of Medicine, Fernando Pessoa Canarias University, 35001 Las Palmas de Gran Canaria, Spain.ORCID 0000-0003-1709-6232
Marta Lloret Sáez-BravoDepartment of Clinical Sciences, University of Las Palmas de Gran Canaria (ULPGC), 35010 Las Palmas de Gran Canaria, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAn accurate prognostic assessment is essential to optimize treatment strategies in head and neck cancer (HNC). This study aimed to develop and internally evaluate an AI-assisted survival risk score derived from automatically quantified cervical muscle parameters on routine radiotherapy-planning CT scans.

methodsPretreatment CT images were processed in a single-center cohort of 65 HNC patients, using AI-assisted automated segmentation to obtain the cervical skeletal muscle index (SMI), intramuscular adipose tissue area (IMAT), and mean muscle attenuation (HU). A multivariable Cox regression model was used to generate the continuous FUNC-RISK score, and model performance was assessed using time-dependent ROC curves at 36 and 60 months.

resultsPatient-, tumor-, and treatment-related characteristics were not predictive of survival. SMI (

conclusionsFUNC-RISK provides preliminary evidence of clinically meaningful prognostic stratification based on AI-derived cervical muscle quantity and quality metrics obtained from routine radiotherapy-planning CT scans. These exploratory results support the potential role of automated body-composition analysis in personalized risk assessment for HNC, although external multicenter validation is required before clinical implementation.

Indexed as

artificial intelligencecancercorporal compositionhead and neckradiotherapy

Identifiers

PMID41463219
PMCPMC12730656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.